LexDanaLexDanabeta
Inventor

Breda TWOMEY

Inventor
GB

Overview

3→
Patents
2023–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07BGeneral methods of organic chemistry14%
C07KPeptides14%
C12NMicroorganisms or enzymes14%
G01NInvestigating or analysing materials by determining their chemical or physical properties14%
PatentTitleYear
12,473,355Gremlin-1 crystal structure and inhibitory antibody202511,975,046Medical use of interferon-lambda for the treatment of fibrosis202411,807,680Gremlin-1 crystal structure and inhibitory antibody2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2025Patents assigned to UCB Biopharma SRL (3)· patent assignee history
2023–2025Based in GB· patent location history
2024Patents assigned to FIVE PRIME THERAPEUTICS INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UCB Biopharma SRL32023–2025
FIVE PRIME THERAPEUTICS INC12024
Locations
LocationPatentsSpan
GB32023–2025